Weitz JI - Search Results

1

Long-term oral anticoagulant therapy in patients with unstable angina or suspected non-Q-wave myocardial infarction: organization to assess strategies for ischemic syndromes (OASIS) pilot study results.

Anand SS, Yusuf S, Pogue J, Weitz JI, Flather M. Anand SS, et al. Among authors: weitz ji. Circulation. 1998 Sep 15;98(11):1064-70. doi: 10.1161/01.cir.98.11.1064. Circulation. 1998. PMID: 9736592 Clinical Trial.

2

A novel and rapid whole-blood assay for D-dimer in patients with clinically suspected deep vein thrombosis.

Wells PS, Brill-Edwards P, Stevens P, Panju A, Patel A, Douketis J, Massicotte MP, Hirsh J, Weitz JI, Kearon C, et al. Wells PS, et al. Among authors: weitz ji. Circulation. 1995 Apr 15;91(8):2184-7. doi: 10.1161/01.cir.91.8.2184. Circulation. 1995. PMID: 7697847

3

Advances in antithrombotic therapy: novel agents.

Turpie AG, Weitz JI, Hirsh J. Turpie AG, et al. Among authors: weitz ji. Thromb Haemost. 1995 Jul;74(1):565-71. Thromb Haemost. 1995. PMID: 8578525 Review.

4

Effect of nonspecific binding to plasma proteins on the antithrombin activities of unfractionated heparin, low-molecular-weight heparin, and dermatan sulfate.

Cosmi B, Fredenburgh JC, Rischke J, Hirsh J, Young E, Weitz JI. Cosmi B, et al. Among authors: weitz ji. Circulation. 1997 Jan 7;95(1):118-24. doi: 10.1161/01.cir.95.1.118. Circulation. 1997. PMID: 8994426

5

Thrombin binds to soluble fibrin degradation products where it is protected from inhibition by heparin-antithrombin but susceptible to inactivation by antithrombin-independent inhibitors.

Weitz JI, Leslie B, Hudoba M. Weitz JI, et al. Circulation. 1998 Feb 17;97(6):544-52. doi: 10.1161/01.cir.97.6.544. Circulation. 1998. PMID: 9494024

6

Vasoflux, a new anticoagulant with a novel mechanism of action.

Weitz JI, Young E, Johnston M, Stafford AR, Fredenburgh JC, Hirsh J. Weitz JI, et al. Circulation. 1999 Feb 9;99(5):682-9. doi: 10.1161/01.cir.99.5.682. Circulation. 1999. PMID: 9950667 Clinical Trial.

7

Prevention of activation of blood coagulation during acute coronary ischemic syndromes: beyond aspirin and heparin.

Bates SM, Weitz JI. Bates SM, et al. Among authors: weitz ji. Cardiovasc Res. 1999 Feb;41(2):418-32. doi: 10.1016/s0008-6363(98)00323-x. Cardiovasc Res. 1999. PMID: 10341841 Review.

8

Beyond heparin and aspirin: new treatments for unstable angina and non-Q-wave myocardial infarction.

Weitz JI, Bates SM. Weitz JI, et al. Arch Intern Med. 2000 Mar 27;160(6):749-58. doi: 10.1001/archinte.160.6.749. Arch Intern Med. 2000. PMID: 10737274 Review.

9

Unfractionated heparin and low-molecular-weight heparin in acute coronary syndrome without ST elevation: a meta-analysis.

Eikelboom JW, Anand SS, Malmberg K, Weitz JI, Ginsberg JS, Yusuf S. Eikelboom JW, et al. Among authors: weitz ji. Lancet. 2000 Jun 3;355(9219):1936-42. doi: 10.1016/S0140-6736(00)02324-2. Lancet. 2000. PMID: 10859038

10

Reactivation of coagulation after stopping infusions of recombinant hirudin and unfractionated heparin in unstable angina and myocardial infarction without ST elevation: results of a randomized trial. OASIS Pilot Study Investigators. Organization to Assess Strategies for Ischemic++ Syndromes.

Flather MD, Weitz JI, Yusuf S, Pogue J, Sussex B, Campeau J, Gill J, Schuld R, Joyner CD, Morris AL, Lai C, Théroux P, Marquis JF, Chan YK, Venkatesh G, Jessel A. Flather MD, et al. Among authors: weitz ji. Eur Heart J. 2000 Sep;21(17):1473-81. doi: 10.1053/euhj.1999.2005. Eur Heart J. 2000. PMID: 10952840 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

558 results

Search Page

Filters